TUCATINIB | TUCATINIB | ATC L01EH03
ANTINEOPLASTIC A TYROSINE KINASE INHIBITOR OF HER2 TREATMENT OF BREAST CANCER | ORAL | Tmax 2 HOUR VD 1670 LITER PPB 97.1 PERCENT Cl 148 LITER / HOUR HT 8.5 HOUR | HER2 | ERBB2,ERBB3 UNIPROT P04626 ERBB2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |